Brief BioFab Inc

CesarLooCEO

USAChilePeruMexicoVenezuela•h6p://www.biofab.com.pe•@BioFabCesarLoor•laboratorio@biofab.com.pe

BioFab Inc wants to increase humans life in 50%. that is why we have developed an organ bank based on stem cells obtained

from the third molar and we have built the bioprinter BioFab 4500 V.1.x to print the organs.

People die because of organ deteroration so creating an organ bank to storage replacements for this organs would extend our lifespan.

OurValueProposiFon

StemCellsonlyumbilicalcord•  Onlybeneficiaries.Newborns•  Twentyyearoldtechnology

OrganShortage•  LongwaiFnglist•  NoncompaFbility

HighCost•  Highmedicalfees

TheProblem

MulFplestemcellextracFonopFon•  Thirdmolarandbabyteeth•  AdiposeFssue

HealthCenters•  Agreewithhospitalsandmedicalclinics•  StemcellapplicaFon

LowCost•  3dprintertechnology•  FromUSD1000.00forfreezestemcell

HowWeCreateValue

HowWe’reUnique

3dPrinterStemCellTechnology

Organtransplant

1.Umbilicalcord2.Thirdmolarandbabyteeth3.AdiposeFssue

Umbilicalcord

LowCost

3dPrinterStemCellTechnology

OurTracFon

0

5

10

15

20

25

30

35

40

45

50

0

50

Q12014 Q22014Q32014_(current)

Q42014_ Q12015 Q22015 Q32015 Q42015

EnterR

even

ueDriv

erHere

Revenu

einTho

usan

ds

Time

SelectClientList

AgreementUPCH

MulFdentHospitalesAngeles

Today

ScaleChileMexico

VenezuelaUSA

ConsolidaFonSouthAmericaNorthAmerica

ScaleEuropeAsia

OurTracFontoDate

2014

2015

2016

CaseStudy

Serve100000dentalpaFents.LaboratoryandStemCell

MainChallenge

•  AgreementI+D+i•  Extraction stem cells of molar and baby teeht

AcFons

2500clientsserver

#20

%USD100,000.00in

sales

$

35MulFdentDentalclinics

Results

0%10%20%30%40%50%60%70%

December2014 April2015

Reho

spita

lizaF

onRate N=[xx]

ExtracFonandCriogenizaFonStemmCelll

MainChallenge

•  AgreementI+D+i•  BuycriogenizaFontanks

AcFons20medicalhospitalin

MexicoDF

Results

60dentalclinicserve

%

CaseStudy[ALTERNATE]

BusinessModel

•  HeathCenteragreement.pay[10%]perclients•  AgreementforI+D+i

PrimaryBusinessModel

•  Medicalsalepay10%perprostheFc•  PR

SecondaryBusinessModel

OurTeam

CesarLooFounder

GabyCoFounder

TheOpportunity

28%

42%

21%

9%

MarkeNng Team Product Other

UseofFundsCurrentlyRaising$100000.00[SeedRound]

PreviouslyRaised$100000.00•  Happyclients•  TeamOK•  SpeakerinBID(InterAmericanBank)

AchievementstoDate

•  IncorporateBioFabinUSA.BioFabInc

•  1Patent

•  IncorporatedBioFabinPeru,Chile,MexicoandVenezuela

•  Buy3dPrinter

ThankYouQ&A

USAChilePeruMexicoVenezuela•h6p://www.biofab.com.pe•@BioFabCesarLoor•laboratorio@biofab.com.pe